Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study

Objectives. To investigate the metabolic profile in patients with aortic stenosis (AS) after transcatheter aortic valve replacement (TAVR) and explore the potential biomarkers to predict prognosis after TAVR based on metabolomics. Methods and Results. Fifty-nine consecutive AS patients were prospect...

Full description

Saved in:
Bibliographic Details
Main Authors: Yanbiao Liao, Chang Liu, Tianyuan Xiong, Mingyue Zhao, Wen Zheng, Yuan Feng, Yijian Li, Yuanweixiang Ou, Zhengang Zhao, Yong Peng, Jiafu Wei, Qiao Li, Wei Meng, Xiaojing Liu, Mao Chen
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2020/3946913
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550451668582400
author Yanbiao Liao
Chang Liu
Tianyuan Xiong
Mingyue Zhao
Wen Zheng
Yuan Feng
Yijian Li
Yuanweixiang Ou
Zhengang Zhao
Yong Peng
Jiafu Wei
Qiao Li
Wei Meng
Xiaojing Liu
Mao Chen
author_facet Yanbiao Liao
Chang Liu
Tianyuan Xiong
Mingyue Zhao
Wen Zheng
Yuan Feng
Yijian Li
Yuanweixiang Ou
Zhengang Zhao
Yong Peng
Jiafu Wei
Qiao Li
Wei Meng
Xiaojing Liu
Mao Chen
author_sort Yanbiao Liao
collection DOAJ
description Objectives. To investigate the metabolic profile in patients with aortic stenosis (AS) after transcatheter aortic valve replacement (TAVR) and explore the potential biomarkers to predict prognosis after TAVR based on metabolomics. Methods and Results. Fifty-nine consecutive AS patients were prospectively recruited. Blood samples from the ascending aorta, coronary sinus, and peripheral vein at before and after TAVR were collected, respectively. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were performed to analyze the metabolic profile before and after TAVR. Influential metabolites were identified by integrating the univariate test, multivariate analysis, and weighted gene coexpression network analysis (WGCNA) algorithm. PLS-DA analysis revealed a significant extremely early (within 30 minutes after TAVR) alterations of metabolites in the ascending aorta, coronary sinus, and peripheral vein. The early (within 7 days after TAVR) changed metabolites in the peripheral vein were involved in purine metabolism, primary bile acid biosynthesis, glycerolipid metabolism, amino sugar and nucleotide sugar metabolism, one carbon pool by folate and alanine, and the aspartate and glutamate metabolism pathway. We used volcano plots to find that the cardiac-specific changed metabolites were enriched to the sphingolipid metabolism pathway after TAVR. Besides, WGCNA algorithm was performed to reveal that arginine and proline metabolites could reflect left ventricle regression to some extent. Conclusion. This is the first study to reveal systemic and cardiac metabolites changed significantly in patients with AS after TAVR. Some altered metabolites involved in the arginine and proline metabolism pathway in the peripheral vein could predict left ventricle regression, which merited further study.
format Article
id doaj-art-d628c36ba5b14de1a90562f7045f394d
institution Kabale University
issn 2090-8016
2090-0597
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-d628c36ba5b14de1a90562f7045f394d2025-02-03T06:06:46ZengWileyCardiology Research and Practice2090-80162090-05972020-01-01202010.1155/2020/39469133946913Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics StudyYanbiao Liao0Chang Liu1Tianyuan Xiong2Mingyue Zhao3Wen Zheng4Yuan Feng5Yijian Li6Yuanweixiang Ou7Zhengang Zhao8Yong Peng9Jiafu Wei10Qiao Li11Wei Meng12Xiaojing Liu13Mao Chen14Department of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaLaboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaLaboratory of Mitochondrial Biology, West China-Washington Mitochondria and Metabolism Center, West China Hospital, Sichuan University, No. 88, Keyuan South Road, High-Tech Zone, Chengdu 610093, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiovascular Surgery, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaLaboratory of Cardiovascular Diseases, Regenerative Medicine Research Center, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaDepartment of Cardiology, West China Hospital, Sichuan University, 37 Guoxue Street, Chengdu 610041, ChinaObjectives. To investigate the metabolic profile in patients with aortic stenosis (AS) after transcatheter aortic valve replacement (TAVR) and explore the potential biomarkers to predict prognosis after TAVR based on metabolomics. Methods and Results. Fifty-nine consecutive AS patients were prospectively recruited. Blood samples from the ascending aorta, coronary sinus, and peripheral vein at before and after TAVR were collected, respectively. Liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry were performed to analyze the metabolic profile before and after TAVR. Influential metabolites were identified by integrating the univariate test, multivariate analysis, and weighted gene coexpression network analysis (WGCNA) algorithm. PLS-DA analysis revealed a significant extremely early (within 30 minutes after TAVR) alterations of metabolites in the ascending aorta, coronary sinus, and peripheral vein. The early (within 7 days after TAVR) changed metabolites in the peripheral vein were involved in purine metabolism, primary bile acid biosynthesis, glycerolipid metabolism, amino sugar and nucleotide sugar metabolism, one carbon pool by folate and alanine, and the aspartate and glutamate metabolism pathway. We used volcano plots to find that the cardiac-specific changed metabolites were enriched to the sphingolipid metabolism pathway after TAVR. Besides, WGCNA algorithm was performed to reveal that arginine and proline metabolites could reflect left ventricle regression to some extent. Conclusion. This is the first study to reveal systemic and cardiac metabolites changed significantly in patients with AS after TAVR. Some altered metabolites involved in the arginine and proline metabolism pathway in the peripheral vein could predict left ventricle regression, which merited further study.http://dx.doi.org/10.1155/2020/3946913
spellingShingle Yanbiao Liao
Chang Liu
Tianyuan Xiong
Mingyue Zhao
Wen Zheng
Yuan Feng
Yijian Li
Yuanweixiang Ou
Zhengang Zhao
Yong Peng
Jiafu Wei
Qiao Li
Wei Meng
Xiaojing Liu
Mao Chen
Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
Cardiology Research and Practice
title Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
title_full Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
title_fullStr Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
title_full_unstemmed Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
title_short Metabolic Modulation and Potential Biomarkers of the Prognosis Identification for Severe Aortic Stenosis after TAVR by a Metabolomics Study
title_sort metabolic modulation and potential biomarkers of the prognosis identification for severe aortic stenosis after tavr by a metabolomics study
url http://dx.doi.org/10.1155/2020/3946913
work_keys_str_mv AT yanbiaoliao metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT changliu metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT tianyuanxiong metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT mingyuezhao metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT wenzheng metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT yuanfeng metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT yijianli metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT yuanweixiangou metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT zhengangzhao metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT yongpeng metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT jiafuwei metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT qiaoli metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT weimeng metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT xiaojingliu metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy
AT maochen metabolicmodulationandpotentialbiomarkersoftheprognosisidentificationforsevereaorticstenosisaftertavrbyametabolomicsstudy